Azalea Therapeutics

BiotechnologySeries ABerkeley, US

Latest round

Series A

Last raised

Nov 2025

Total raised

$65M

Investors

4

About Azalea Therapeutics

Azalea Therapeutics, Inc.Founded in 2023 by Jenny Hamilton (CEO), Connor Tsuchida, Abdullah Syed, Jennifer Doudna, Justin Eyquem, and Michael Fischbach and headquartered in Berkeley, US, Azalea Therapeutics, Inc. specializes in CAR-T therapies for treating various diseases. The company was established to address significant unmet medical needs in oncology and autoimmune disorders.00 mn completed on November 4, 2025.Azalea Therapeutics, Inc. focuses on developing in vivo CAR-T therapies, primarily targeting B-cell malignancies and autoimmune diseases. Their flagship product is a CD19-based therapeutic approach designed to enhance patient outcomes.Azalea Therapeutics, Inc.Azalea Therapeutics, Inc. Additionally, the firm intends to develop new programs aimed at treating multiple myeloma and solid tumors.

Who invested in Azalea Therapeutics

4 investors across 1 round

See all investors in Azalea Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 4, 2025

    Amount

    $65M

    Investors

    Locked

Questions about Azalea Therapeutics

Who invested in Azalea Therapeutics?

Azalea Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Azalea Therapeutics raised?

Azalea Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Azalea Therapeutics last raise money?

Azalea Therapeutics's most recent round on record is a Series A, in Nov 2025.

What does Azalea Therapeutics do?

Azalea Therapeutics is a biotechnology company.

Where is Azalea Therapeutics headquartered?

Azalea Therapeutics is headquartered in Berkeley, US.

Which VCs invest in companies like Azalea Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Azalea Therapeutics's stage. Their profiles are linked below.

Raising like Azalea Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.